Brief: Cantargia Receives USPTO Notice Of Allowance For Composition Of Matter Patent On Antibody CAN10
21/07/2022 08:46
July 21 (Reuters) - Cantargia AB CANTA.ST :
* CANTARGIA RECEIVES USPTO NOTICE OF ALLOWANCE FOR
COMPOSITION OF
MATTER PATENT ON ANTIBODY CAN10
* APPLICATION DESCRIBES COMPOSITION OF MATTER FOR
ANTI-INFLAMMATORY IL1RAP-BINDING ANTIBODY CAN10, WHICH CANTARGIA
PLANS TO BRING TO PHASE I CLINICAL DEVELOPMENT EARLY 2023
Source text for Eikon: ID:nWkr8mLMpP
Further company coverage: CANTA.ST
(Gdansk Newsroom)
((Gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Cantargia AB
See all newsBrief: Cantargia Publishes Nadunolimab CANFOUR Study Data
Brief: Cantargia Announces Outcome Of Rights Issue, Raising About SEK 75 Mln
Brief: Cantargia Carries Out Rights Issue, Enters Loan Agreement
Brief: Cantargia Q1 Operating Loss Narrows To SEK 36.9 Mln
Brief: Cantargia: Early Results From Phase 1B/2A Nadunolimab Trial In MDS And AML